Pfizer (NYSE:PFE) Hits New 1-Year Low - What's Next?

Motley Fool: Pfizer remains a dividend giant

You may know 175-year-old pharmaceutical company Pfizer (NYSE: PFE) best for its COVID-19 vaccine, but investors have long known the company as a reliable dividend payer. Pfizer has increased its dividend for 16 straight years, and its dividend yield was recently a fat 7.1%, meaning that a $1,000 position in the stock would generate $71 over a year.

Pfizer (NYSE:PFE) Hits New 1-Year Low - What's Next?

Pfizer (NYSE:PFE) Reaches New 1-Year Low - Time to Sell?

Accredited Investors Inc. Has $507,000 Holdings in Pfizer Inc. (NYSE:PFE)

Accredited Investors Inc. trimmed its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 5.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,093 shares of the biopharmaceutical company’s stock after selling 1,086 shares during the period. Accredited Investors […]

First Foundation Advisors Sells 13,913 Shares of Pfizer Inc. (NYSE:PFE)

First Foundation Advisors trimmed its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 6.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 189,024 shares of the biopharmaceutical company’s stock after selling 13,913 shares during the period. First Foundation Advisors’ holdings in Pfizer were worth $5,015,000 at the end of the most […]

Pfizer (NYSE:PFE) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on April 07th, the Representative disclosed that they had sold between $15,001 and $50,000 in Pfizer stock on March 31st. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account. Representative Gilbert Ray […]

Pfizer (NYSE:PFE) Shares Down 2.7% Following Analyst Downgrade

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) were down 2.7% during trading on Wednesday after UBS Group lowered their price target on the stock from $28.00 to $24.00. UBS Group currently has a neutral rating on the stock. Pfizer traded as low as $20.92 and last traded at $21.24. Approximately 28,424,445 shares traded hands during trading, a decline of 29% from the average daily volume of 39,806,359 shares. The stock had previously closed a…